Portal Innovations CEO on Future of US Medical Research
Share
The Trump administration is advancing a plan to allocate $200 billion annually toward medical research, emphasizing support for individual scientists and private research facilities rather than traditional university-based research. John Flavin, CEO of Portal Innovations, a Chicago-based firm that funds early-stage life sciences companies, discussed the implications of this shift. He speaks with Romaine Bostick on "The Close."
More from Australia
Greenvale Energy begins grant-funded airborne uranium survey
Osmond Resources raises $3.8M for critical project
Orthocell partner secures FDA clearance for PearlBone
Novo Resources advances exploration with 2,700m drilling campaign
Dynamic Metals acquires 70% project earn-in option
Schoolblazer raises $5.3M in placement